Last reviewed · How we verify

Hyaluronic acid vaginal gel

Koru Health Groups · Phase 1 active Small molecule

Hyaluronic acid vaginal gel is a Small molecule drug developed by Koru Health Groups. It is currently in Phase 1 development.

At a glance

Generic nameHyaluronic acid vaginal gel
SponsorKoru Health Groups
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Hyaluronic acid vaginal gel

What is Hyaluronic acid vaginal gel?

Hyaluronic acid vaginal gel is a Small molecule drug developed by Koru Health Groups.

Who makes Hyaluronic acid vaginal gel?

Hyaluronic acid vaginal gel is developed by Koru Health Groups (see full Koru Health Groups pipeline at /company/koru-health-groups).

What development phase is Hyaluronic acid vaginal gel in?

Hyaluronic acid vaginal gel is in Phase 1.

Related